Results from Upadacitinib Phase 3 SELECT-MONOTHERAPY Study Published in The Lancet - PharmiWeb.com

Results from Upadacitinib Phase 3 SELECT-MONOTHERAPY Study Published in The Lancet  PharmiWeb.com

Maidenhead, 28 May, 2019 — AbbVie (NYSE: ABBV), a global biopharmaceutical company, today announced the publication of positive results from the pivotal ...



Comments

Post a Comment

Popular posts from this blog